Creating a Pathway for Disease-Free Cancer Survivors to Decrease Long-term Opioid Use
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Pain
- 发起方
- Virginia Commonwealth University
- 入组人数
- 18
- 试验地点
- 1
- 主要终点
- Recruitment yield number of participants enrolled
- 状态
- 暂停
- 最后更新
- 8个月前
概览
简要总结
This is a feasibility pilot trial assessing a behavioral intervention for chronic pain among disease-free cancer survivors to decrease long-term opioid dependence.
详细描述
To assess the feasibility and acceptability of implementing brief Acceptance and Commitment Therapy for chronic pain (ACT-CP) in a Survivorship clinic.
研究者
入排标准
入选标准
- •Diagnosis of cancer of any type, currently in remission, having completed active primary therapy. Patients on oral adjuvant hormone therapy will still be eligible.
- •Completed active therapy must have been curative in intent (for example stage IV cancer patients such as head and neck cancer patients treated with curative intent are eligible).
- •Self-reported cancer pain for \>= 3 months
- •Opioid use \>= 5MME/day (morphine milligram equivalents) as prescribed by physician for cancer-related pain for at least 6 months beyond completion of their cancer treatment
- •VCUHealth system patient
排除标准
- •History of opioid use prior to cancer diagnosis
- •Anyone with prior history of substance use disorder or currently enrolled in a methadone program
- •Anyone with schizophrenia or bipolar disorder
- •Current utilization of psychotherapy services for pain, depression, anxiety, and/or PTSD
- •Cognitive concerns that would prevent meaningful engagement in treatment
- •Inability to converse in English
- •Lack of working telephone and Internet connection (must have at least one or the other)
- •Anyone found to have progression of cancer
- •Anyone diagnosed with cancer recurrence or new cancer during their study period
- •Documented diagnosis of or positive screen for current substance use disorder (score \>5 on the Drug Abuse Screening Test-10 \[DAST-10\])
结局指标
主要结局
Recruitment yield number of participants enrolled
时间窗: 12 Months
Study feasibility will be assessed by recruitment yield, i.e., tracking the number of participants who initiated treatment.
Recruitment yield of participants consented
时间窗: 12 Months
Study feasibility will be assessed by tracking the number of participants that consent to enroll in the trial.
Session Attendance
时间窗: 6 Weeks
Study feasibility will be assessed by tracking the number of participants attend each intervention session over the course of the 6-week intervention period.
Participant Satisfaction
时间窗: 6 Weeks
Study acceptability will be assessed by administering a post-intervention satisfaction survey which asks about satisfaction with the program including perceived efficacy and suggestions for improvement.
Recruitment yield of participants contacted
时间窗: 12 Months
Study feasibility will be assessed by tracking the number of patients contacted
次要结局
- Opioid Use Frequency(6 Weeks)
- Pain Intensity(6 Weeks)
- Pain interference(6 Weeks)
- Opioid Refill Frequency(6 Weeks)